Supplementary Figure 10 from Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine TreatmentDaniel Braas, Heather R. Christofk, Ethan Ahler et al.|Unknown|2023Cited by 0
Supplementary Figures 1-4 from Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine TreatmentDaniel Braas, Heather R. Christofk, Kathleen B. Smith et al.|Unknown|2023Cited by 0
Supplementary Figures 1 - 4 from Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine TreatmentDaniel Braas, Heather R. Christofk, Hong Wu et al.|Unknown|2023Cited by 0